From Petri Dishes to the Patent Office: LMU and MSMU Professors Patent Synthetic Peptide That Could Slow Diabetes More than 40 million Americans live with diabetes, and between 90% to 95% of them have Type 2 – with more children, teens, and young adults developing the disease than ever before. While most…
LMU, Mount Saint Mary’s University Secure U.S. Patent for Novel Peptide Targeting Type 2 Diabetes 16-year faculty collaboration engages more than 200 undergraduate researchers in breakthrough discovery LOS ANGELES — Loyola Marymount University and Mount Saint Mary’s University have jointly secured a U.S. patent for a synthetic peptide designed…
LMU Biochemist Awarded NIH Grant to Study Protein’s Role in Diabetes The National Institutes of Health (NIH) National Institute for Diabetes and Digestive and Kidney Diseases awarded David Moffet, Loyola Marymount University professor of chemistry and biochemistry, a three-year $407,364 grant to continue studying a…